CreatorsPublishersAdvertisers
View more in
Business

PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend

technologynetworks.com
 2021-09-24

Cover picture for the articlePerkinElmer, Inc. (NYSE: PKI) has announced it has completed its acquisition of BioLegend, a leading, worldwide provider of life science antibodies and reagents for a total consideration of approximately $5.25 billion. The acquisition, the largest in PerkinElmer’s history, further expands the Company’s life...

www.technologynetworks.com

Comments / 0

Comments / 0